Heist, R., Shum, E., Garcia, E., Itchins, M., Gao, B., Han, J., Blumenschein, G. R., Benafif, S., Alexander, M., Joshi, R., Lee, J., Coupe, N., Girard, N., Fiske, B., Traianova, M., Downing, W. T., Nguyen, T., Wu, T., Gallant, G., Kim, H. R. (2025). MYTX-011, a cMET-targeting antibody-drug conjugate (ADC), in patients with previously treated, advanced NSCLC: Updated dose escalation results in the phase 1 KisMET-01 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.8613